Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

393
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
393
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.2K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

337
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
337
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

11.6K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vitro Toxicity Assessment of Pre- and Post-incinerated Organomodified Nanoclays on Airway Epithelial and Lung Fibroblast Cells.

Chemical research in toxicology·2025
Same author

Development of Preliminary Candidate Surface Guidelines for Air Force-Relevant Dermal Sensitizers Using New Approach Methodologies.

Toxics·2025
Same author

Evaluation of a high-throughput in-vitro-to-in-vivo extrapolation (IVIVE) workflow for the prioritization of potential developmental toxicity of chemicals.

ALTEX·2025
Same author

The influence of surface coating on PFAS filter performance.

The Journal of chemical physics·2025
Same author

Prediction of Respiratory Irritation and Respiratory Sensitization of Chemicals Using Structural Alerts and Machine Learning Modeling.

Toxics·2025
Same author

Gene regulation and signaling pathways in immune response to respiratory sensitizers: a database analysis.

Frontiers in immunology·2025
Same journal

AmesNet: A Task-Conditioned Deep Learning Model with Enhanced Sensitivity and Generalization in Ames Mutagenicity Prediction.

Chemical research in toxicology·2026
Same journal

DNA Structure-Dependent Enrichment of Oxidative Lesions.

Chemical research in toxicology·2026
Same journal

Characterizing the Reactive Metabolites of Colony-Stimulating Factor 1 Receptor Inhibitor PLX5622 in Liver Microsomes and Mice.

Chemical research in toxicology·2026
Same journal

Quantitation of E-Cigarette Aerosol Mass in Liquid Impinger Solution Using the <sup>13</sup>C of E-Liquids: Application for Metal Analyses.

Chemical research in toxicology·2026
Same journal

Beyond Heuristics: A Model-Agnostic Framework for Uncertainty Quantification in QSAR via Adaptive Conformal Prediction.

Chemical research in toxicology·2026
Same journal

20-Hydroxyeicosatetraenoic Acid Ameliorates Nickel Nanoparticle-Induced Epithelial-Mesenchymal Transition by Modulating the FFAR1/NF-kB Pathway.

Chemical research in toxicology·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.4K

Multitask Pretraining Framework for Improving Predictivity of Machine Learning Chemical Bioactivity Models for

Noah J Wichrowski1, Mary Versa Clemens-Sewall1, Karun K Rao1

  • 1The Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland 20723, United States.

Chemical Research in Toxicology
|March 26, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a new machine learning pipeline for chemical hazard screening. The multitask model improves predictions for new toxicological endpoints, even with limited data, outperforming traditional methods.

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Related Experiment Videos

Last Updated: Mar 28, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.4K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Area of Science:

  • Computational toxicology
  • Machine learning in drug discovery
  • Chemical risk assessment

Background:

  • Quantitative structure-activity relationship (QSAR) models are vital for chemical hazard screening.
  • Single-task machine learning (ML) models lack transferability and require retraining for new endpoints.
  • Existing models struggle with small, noisy datasets common in toxicology.

Purpose of the Study:

  • To develop an ML approach for predicting chemical bioactivity on low-data toxicological endpoints.
  • To create a multitask ML model that can be adapted for novel prediction tasks.
  • To improve the utility of ML QSAR methods for hazard screening.

Main Methods:

  • Trained a multitask ML model on multiple ToxCast datasets (moderate size).
  • Combined the pretrained multitask model with task-specific predictors (random forest, neural network) for novel predictions on small datasets.
  • Utilized molecular representations generated by the multitask model.

Main Results:

  • The novel ML pipeline demonstrated statistically superior performance on most tasks compared to standard ML approaches.
  • The multitask model's molecular representations captured generalizable information by integrating data from multiple endpoints.
  • The approach effectively handled multiple small, noisy datasets.

Conclusions:

  • The developed ML pipeline enhances the prediction of chemical bioactivity for under-resourced toxicological endpoints.
  • Multitask learning provides a more robust and transferable approach for QSAR modeling in toxicology.
  • This work advances the application of ML for efficient and reliable chemical hazard screening.